期刊文献+

首诊时伴血清甲胎蛋白升高胃癌的临床病理特点和预后分析

Initially diagnosed gastric cancer with elevated serum alpha-fetoprotein:a systemic analysis of clinicopathological features and prognosis
下载PDF
导出
摘要 目的:探讨首诊时伴血清AFP升高的胃癌的临床病理特点及预后。方法:收集中国人民解放军联勤保障部队第904医院安徽医科大学无锡临床医学院2008年1月至2020年12月经胃镜活检首诊为胃腺癌的931例患者,以血清AFP≥20 ng/mL为标准筛选病例。H&E染色、免疫组织化学法和特殊染色明确病理学特点和免疫表型,并分析患者的临床特点和生存期。结果:931例胃腺癌中有36例(3.9%)首诊时出现血清AFP升高(20.7~6558.0 ng/mL)。患者无特异临床表现,影像学检查发现,36例患者中17例有远处转移,以肝转移最多见(13例),其余19例患者无远处转移。远处转移的病例其血清AFP水平明显高于无转移者(P=0.003)。病理分析显示,36例患者中16例为肝样腺癌,11例为伴有肠母细胞分化的腺癌,9例为普通腺癌。上述胃癌亚型均表达原始分化的标志物SALL4、GPC3、AFP。随访显示,无远处转移的19例患者的总生存期明显高于有远处转移的17例患者(P=0.002)。无远处转移的19例患者有16例进行了胃癌根治手术,其与经手术根治的AFP正常的314例普通胃癌相比,无病生存期更短(P=0.044),但总生存期差异无统计学意义(P=0.093)。结论:首诊时伴血清AFP升高的胃癌较罕见,其病理类型主要为肝样腺癌和伴有肠母细胞分化的腺癌。此类患者近一半在首诊时可见以肝脏为主的远处转移,有远处转移者预后极差,而无远处转移者手术治疗后预后较好,但相对于无AFP升高的胃癌预后仍可能较差。 Objective:To systemically analyze the clinicopathological features and prognosis of initially diagnosed gastric cancer with an elevated serumα-fetoprotein(AFP)level.Methods:The cases of 931 hospital inpatients diagnosed with gastric adenocarcinoma via endoscopic biopsy from January 2008 to December 2020 were collected;those with a serum AFP level≥20 ng/mL were investigated further.Hematoxylin and eosin,immunohistochemical,and special staining were employed to determine their pathological features and immunophenotypes,while their clinical features and survival were analyzed.Results:Of the 931 cases of gastric adenocarcinoma,3.9%(36/931)exhibited high serum AFP levels(range,20.7-16,558 ng/mL);none showed any special clinical manifestations.At the time of diagnosis,radiological examinations showed distant metastasis in 17 cases(13 to the liver)but not in the remaining 19.Cases with distant metastasis showed a significantly higher AFP level than those without(P=0.003).The 36 cases included hepatoid adenocarcinoma(16 cases),adenocarcinoma with enteroblastic differentiation(11 cases),and conventional adenocarcinoma(9 cases).Three primitive phenotypic markers-SALL4,GPC-3,and AFP-were expressed in these subtypes.Prognosis analysis demonstrated that 19 cases with versus without distant metastasis had a better overall survival(OS)rate(P=0.002).Sixteen of the 19 cases without distant metastasis were treated with curative gastrectomy.The 16 surgically treated cases had a worse disease-free survival(P=0.044)rate than the 314 cases of gastric cancer with normal serum AFP levels,while the OS rate was comparable between them(P=0.093).Conclusions:Initially diagnosed gastric cancer with an elevated serum AFP level is rare and predominantly consists of hepatoid adenocarcinoma and adenocarcinoma with enteroblastic differentiation.Approximately onehalf of these cases featured distant metastasis at the time of diagnosis,which led to an unfavorable prognosis.The prognosis may be worse for cases without distant metastasis than those of gastric cancer with a normal serum AFP level.
作者 周志华 赵海滨 王倩 张俊杰 Zhihua Zhou;Haibin Zhao;Qian Wang;Junjie Zhang(Department of Pathology,The 904 Hospital of Joint Service Support Force,PLA,Wuxi Clinical Collage of Anhui Medical University,Wuxi 214044,China)
出处 《中国肿瘤临床》 CAS CSCD 北大核心 2023年第20期1040-1045,共6页 Chinese Journal of Clinical Oncology
基金 安徽医科大学校科研基金项目(编号:2021xkj245)资助。
关键词 胃腺癌 甲胎蛋白 肝样腺癌 伴有肠母细胞分化的腺癌 预后 gastric cancer α-fetoprotein(AFP) hepatoid adenocarcinoma adenocarcinoma with enteroblastic differentiation prognosis
  • 相关文献

参考文献2

二级参考文献10

  • 1Yung-Jue Bang,Eric Van Cutsem,Andrea Feyereislova,Hyun C Chung,Lin Shen,Akira Sawaki,Florian Lordick,Atsushi Ohtsu,Yasushi Omuro,Taroh Satoh,Giuseppe Aprile,Evgeny Kulikov,Julie Hill,Michaela Lehle,Josef Rüschoff,Yoon-Koo Kang.Trastuzumab in combination with chemotherapy versus chemotherapy alone for treatment of HER2-positive advanced gastric or gastro-oesophageal junction cancer (ToGA): a phase 3, open-label, randomised controlled trial[J].The Lancet.2010(9742)
  • 2Jong-Han Kim,You-Jin Jang,Sung-Soo Park,Seong-Heum Park,Young-Jae Mok.Benefit of Post-operative Surveillance for Recurrence after Curative Resection for Gastric Cancer[J].Journal of Gastrointestinal Surgery.2010(6)
  • 3Narikazu Boku,Seiichiro Yamamoto,Haruhiko Fukuda,Kuniaki Shirao,Toshihiko Doi,Akira Sawaki,Wasaburo Koizumi,Hiroshi Saito,Kensei Yamaguchi,Hiroya Takiuchi,Junichiro Nasu,Atsushi Ohtsu.Fluorouracil versus combination of irinotecan plus cisplatin versus S-1 in metastatic gastric cancer: a randomised phase 3 study[J].Lancet Oncology.2009(11)
  • 4Wasaburo Koizumi,Hiroyuki Narahara,Takuo Hara,Akinori Takagane,Toshikazu Akiya,Masakazu Takagi,Kosei Miyashita,Takashi Nishizaki,Osamu Kobayashi,Wataru Takiyama,Yasushi Toh,Takashi Nagaie,Seiichi Takagi,Yoshitaka Yamamura,Kimihiko Yanaoka,Hiroyuki Orita,Masahiro Takeuchi.S-1 plus cisplatin versus S-1 alone for first-line treatment of advanced gastric cancer (SPIRITS trial): a phase III trial[J].Lancet Oncology.2008(3)
  • 5Naohiko Koide,Akihito Nishio,Jun Igarashi,Shoji Kajikawa,Wataru Adachi,Jun Amano.α-Fetoprotein–producing gastric cancer: histochemical analysis of cell proliferation, apoptosis, and angiogenesis[J].The American Journal of Gastroenterology.1999(6)
  • 6Takashi Aiko,Mitsuru Sasako.The new Japanese Classification of Gastric Carcinoma: Points to be revised[J].Gastric Cancer.1998(1)
  • 7Shohei Koyama M.D.,Tsugio Ebihara M.D.,Toshiaki Osuga M.D.Histologic and immunohistochemical studies of alpha-fetoprotein (AFP)-producing gastric carcinoma[J].Gastroenterologia Japonica.1987(4)
  • 8C. G. Bergstrand,Birgit Czar.Demonstration of a New Protein Fraction in Serum from the Human Fetus[J].Scandinavian Journal of Clinical & Laboratory Investigation.1956(2)
  • 9胃癌HER2检测指南(2016版)[J].中华病理学杂志,2016,45(8):528-532. 被引量:93
  • 10杨沁怡,何如吉,化宏金,沈历宗,张智弘.伴血清甲胎蛋白升高的胃癌64例临床病理学分析[J].中华病理学杂志,2017,46(12):855-856. 被引量:5

共引文献40

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部